NEW YORK
(MarketWatch) -- Pfizer Inc. is negotiating to acquire rival drug maker
Wyeth in a blockbuster deal potentially worth more than $60 billion
that could alter the global drug industry, the Wall Street Journal
reported Friday.
News of the possible deal sent shares of Wyeth up 13% in premarket
trading Friday, while shares of Pfizer slipped about 2.7%.
Positions: Long Wyeth & Pfizer
Positions: Long Wyeth & Pfizer
Comments